Adverum Biotechnologies Inc (ADVM)
6.04
+0.29
(+5.04%)
USD |
NASDAQ |
Nov 22, 16:00
6.05
+0.01
(+0.17%)
After-Hours: 20:00
Adverum Biotechnologies Total Return Price: 6.04 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 6.04 |
November 21, 2024 | 5.75 |
November 20, 2024 | 6.17 |
November 19, 2024 | 6.25 |
November 18, 2024 | 6.85 |
November 15, 2024 | 6.86 |
November 14, 2024 | 7.25 |
November 13, 2024 | 7.56 |
November 12, 2024 | 7.89 |
November 11, 2024 | 7.76 |
November 08, 2024 | 8.00 |
November 07, 2024 | 7.90 |
November 06, 2024 | 7.94 |
November 05, 2024 | 7.72 |
November 04, 2024 | 7.54 |
November 01, 2024 | 7.41 |
October 31, 2024 | 7.295 |
October 30, 2024 | 7.88 |
October 29, 2024 | 7.76 |
October 28, 2024 | 7.92 |
October 25, 2024 | 7.98 |
October 24, 2024 | 8.08 |
October 23, 2024 | 8.12 |
October 22, 2024 | 8.14 |
October 21, 2024 | 8.26 |
Date | Value |
---|---|
October 18, 2024 | 8.48 |
October 17, 2024 | 8.08 |
October 16, 2024 | 8.21 |
October 15, 2024 | 7.69 |
October 14, 2024 | 7.73 |
October 11, 2024 | 7.65 |
October 10, 2024 | 7.44 |
October 09, 2024 | 7.52 |
October 08, 2024 | 7.61 |
October 07, 2024 | 7.44 |
October 04, 2024 | 7.53 |
October 03, 2024 | 7.28 |
October 02, 2024 | 6.82 |
October 01, 2024 | 6.59 |
September 30, 2024 | 7.02 |
September 27, 2024 | 6.94 |
September 26, 2024 | 6.61 |
September 25, 2024 | 6.59 |
September 24, 2024 | 6.94 |
September 23, 2024 | 6.88 |
September 20, 2024 | 7.49 |
September 19, 2024 | 7.50 |
September 18, 2024 | 6.99 |
September 17, 2024 | 7.30 |
September 16, 2024 | 7.21 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
5.40
Minimum
Dec 27 2022
256.40
Maximum
Jun 23 2020
47.87
Average
16.03
Median
Total Return Price Benchmarks
EyePoint Pharmaceuticals Inc | 8.95 |
Cassava Sciences Inc | 26.48 |
Regenxbio Inc | 9.59 |
Editas Medicine Inc | 2.44 |
Apellis Pharmaceuticals Inc | 30.77 |